These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 33245505)

  • 1. COVID-19 mortality risk factors in older people in a long-term care center.
    Heras E; Garibaldi P; Boix M; Valero O; Castillo J; Curbelo Y; Gonzalez E; Mendoza O; Anglada M; Miralles JC; Llull P; Llovera R; Piqué JM
    Eur Geriatr Med; 2021 Jun; 12(3):601-607. PubMed ID: 33245505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
    Million M; Lagier JC; Tissot-Dupont H; Ravaux I; Dhiver C; Tomei C; Cassir N; Delorme L; Cortaredona S; Amrane S; Aubry C; Bendamardji K; Berenger C; Doudier B; Edouard S; Hocquart M; Mailhe M; Porcheto C; Seng P; Triquet C; Gentile S; Jouve E; Giraud-Gatineau A; Chaudet H; Camoin-Jau L; Colson P; Gautret P; Fournier PE; Maille B; Deharo JC; Habert P; Gaubert JY; Jacquier A; Honore S; Guillon-Lorvellec K; Obadia Y; Parola P; Brouqui P; Raoult D
    Rev Cardiovasc Med; 2021 Sep; 22(3):1063-1072. PubMed ID: 34565108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):19-27. PubMed ID: 32860962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of SARS-CoV-2 infection among dependant elderly residents living in long-term care facilities in Marseille, France, March-June 2020.
    Ly TDA; Zanini D; Laforge V; Arlotto S; Gentile S; Mendizabal H; Finaud M; Morel D; Quenette O; Malfuson-Clot-Faybesse P; Midejean A; Le-Dinh P; Daher G; Labarriere B; Morel-Roux AM; Coquet A; Augier P; Parola P; Chabriere E; Raoult D; Gautret P
    Int J Antimicrob Agents; 2020 Dec; 56(6):106219. PubMed ID: 33189890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU.
    Çalık Başaran N; Uyaroğlu OA; Telli Dizman G; Özışık L; Şahin TK; Taş Z; İnkaya AÇ; Karahan S; Alp Ş; Alp A; Metan G; Zarakol P; Sain Güven G; Öz ŞG; Topeli A; Uzun Ö; Akova M; Ünal S
    Turk J Med Sci; 2021 Apr; 51(2):411-420. PubMed ID: 32718127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.
    Arshad S; Kilgore P; Chaudhry ZS; Jacobsen G; Wang DD; Huitsing K; Brar I; Alangaden GJ; Ramesh MS; McKinnon JE; O'Neill W; Zervos M;
    Int J Infect Dis; 2020 Aug; 97():396-403. PubMed ID: 32623082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
    Lagier JC; Million M; Gautret P; Colson P; Cortaredona S; Giraud-Gatineau A; Honoré S; Gaubert JY; Fournier PE; Tissot-Dupont H; Chabrière E; Stein A; Deharo JC; Fenollar F; Rolain JM; Obadia Y; Jacquier A; La Scola B; Brouqui P; Drancourt M; Parola P; Raoult D;
    Travel Med Infect Dis; 2020; 36():101791. PubMed ID: 32593867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
    Rosenberg ES; Dufort EM; Udo T; Wilberschied LA; Kumar J; Tesoriero J; Weinberg P; Kirkwood J; Muse A; DeHovitz J; Blog DS; Hutton B; Holtgrave DR; Zucker HA
    JAMA; 2020 Jun; 323(24):2493-2502. PubMed ID: 32392282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
    Million M; Lagier JC; Gautret P; Colson P; Fournier PE; Amrane S; Hocquart M; Mailhe M; Esteves-Vieira V; Doudier B; Aubry C; Correard F; Giraud-Gatineau A; Roussel Y; Berenger C; Cassir N; Seng P; Zandotti C; Dhiver C; Ravaux I; Tomei C; Eldin C; Tissot-Dupont H; Honoré S; Stein A; Jacquier A; Deharo JC; Chabrière E; Levasseur A; Fenollar F; Rolain JM; Obadia Y; Brouqui P; Drancourt M; La Scola B; Parola P; Raoult D
    Travel Med Infect Dis; 2020; 35():101738. PubMed ID: 32387409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine / azithromycin in COVID-19: The association between time to treatment and case fatality rate.
    Accinelli RA; Ynga-Meléndez GJ; León-Abarca JA; López LM; Madrid-Cisneros JC; Mendoza-Saldaña JD
    Travel Med Infect Dis; 2021; 44():102163. PubMed ID: 34534686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Outbreak in Italy: Report on the First 124 Consecutive Patients Treated at Home.
    Cavanna L; Cremona G; Citterio C; Nunzio CD; Muroni M; Andena AM; Cattadori E; Gubbelini M; Muroni L; Schiavo R; Nolli M; Codeluppi M; Maniscalco P; Pedrazzini G
    Tohoku J Exp Med; 2021 Sep; 255(1):61-69. PubMed ID: 34588347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
    Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
    Clin Microbiol Infect; 2021 Jan; 27(1):138-140. PubMed ID: 33080383
    [No Abstract]   [Full Text] [Related]  

  • 13. The interplay between infection risk factors of SARS-CoV-2 and mortality: a cross-sectional study from a cohort of long-term care nursing home residents.
    Soldevila L; Prat N; Mas MÀ; Massot M; Miralles R; Bonet-Simó JM; Isnard M; Expósito-Izquierdo M; Garcia-Sanchez I; Rodoreda-Noguerola S; Moreno N; Badia E; López G; Sevilla J; Estrada O; Vallès X
    BMC Geriatr; 2022 Feb; 22(1):123. PubMed ID: 35164680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
    Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
    PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality.
    De Schryver N; Serck N; Vinetti M; Gérard L
    Int J Antimicrob Agents; 2021 Jan; 57(1):106254. PubMed ID: 33259917
    [No Abstract]   [Full Text] [Related]  

  • 17. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
    Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
    Mori N; Katayama M; Nukaga S
    J Microbiol Immunol Infect; 2021 Feb; 54(1):109-112. PubMed ID: 33054978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
    Rubin GA; Desai AD; Chai Z; Wang A; Chen Q; Wang AS; Kemal C; Baksh H; Biviano A; Dizon JM; Yarmohammadi H; Ehlert F; Saluja D; Rubin DA; Morrow JP; Avula UMR; Berman JP; Kushnir A; Abrams MP; Hennessey JA; Elias P; Poterucha TJ; Uriel N; Kubin CJ; LaSota E; Zucker J; Sobieszczyk ME; Schwartz A; Garan H; Waase MP; Wan EY
    JAMA Netw Open; 2021 Apr; 4(4):e216842. PubMed ID: 33890991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid.
    Rodriguez-Gonzalez CG; Chamorro-de-Vega E; Valerio M; Amor-Garcia MA; Tejerina F; Sancho-Gonzalez M; Narrillos-Moraza A; Gimenez-Manzorro A; Manrique-Rodriguez S; Machado M; Olmedo M; Escudero-Vilaplana V; Villanueva-Bueno C; Torroba-Sanz B; Melgarejo-Ortuño A; Vicente-Valor J; Herranz A; Bouza E; Muñoz P; Sanjurjo M
    Int J Antimicrob Agents; 2021 Feb; 57(2):106249. PubMed ID: 33259918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.